Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ARID1B mutation
i
Other names:
ARID1B, AT-Rich Interaction Domain 1B, AT-Rich Interactive Domain-Containing Protein 1B, AT Rich Interactive Domain 1B (SWI1-Like), ARID Domain-Containing Protein 1B, BRG1-Associated Factor 250b, BAF250B, P250R, DAN15, OSA2, BRG1-Binding Protein HELD/OSA1, BRG1-Binding Protein ELD/OSA1, ELD (Eyelid)/OSA Protein, Osa Homolog 2, ELD/OSA1, KIAA1235, BRIGHT, 6A3-5, MRD12, HOsa2, CSS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
57492
Related biomarkers:
Expression
CNA
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ARID1B mutation
Non Small Cell Lung Cancer
ARID1B mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
ARID1B mutation
Follicular Lymphoma
ARID1B mutation
Follicular Lymphoma
Resistant: C3 – Early Trials
Resistant
:
C3
Resistant: C3 – Early Trials
Resistant
:
C3
ARID1B mutation
Gastrointestinal Cancer
ARID1B mutation
Gastrointestinal Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
ARID1B mutation
Solid Tumor
ARID1B mutation
Solid Tumor
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.